Eberechukwu Onukwugha

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. pmc Reasons for discharges against medical advice: a qualitative study
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Qual Saf Health Care 19:420-4. 2010
  2. ncbi request reprint Skeletal-related events and mortality among older men with advanced prostate cancer
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA Electronic address
    J Geriatr Oncol 5:281-9. 2014
  3. pmc Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    BMC Med Res Methodol 14:1. 2014
  4. doi request reprint Readmissions after unauthorized discharges in the cardiovascular setting
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 49:215-24. 2011
  5. ncbi request reprint Racial differences in hospital discharge disposition among stroke patients in Maryland
    Ebere Onukwugha
    University of Maryland, School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, MD 21201, USA
    Med Decis Making 27:233-42. 2007
  6. ncbi request reprint Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease
    Ebere Chukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Ethn Dis 19:172-8. 2009
  7. ncbi request reprint The total economic burden of overactive bladder in the United States: a disease-specific approach
    Ebere Onukwugha
    Department of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA
    Am J Manag Care 15:S90-7. 2009
  8. doi request reprint The dual impact of rehabilitation admission and race/ethnicity on discharges against medical advice
    E Onukwugha
    Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    NeuroRehabilitation 24:67-74. 2009
  9. doi request reprint Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system
    Ebere Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
    Value Health 11:980-8. 2008
  10. doi request reprint Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Urology 77:1088-95. 2011

Collaborators

Detail Information

Publications29

  1. pmc Reasons for discharges against medical advice: a qualitative study
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Qual Saf Health Care 19:420-4. 2010
    ..The objective of this study is to identify the reasons for DAMA based on patient and multicategory provider focus-group interviews (FGIs)...
  2. ncbi request reprint Skeletal-related events and mortality among older men with advanced prostate cancer
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA Electronic address
    J Geriatr Oncol 5:281-9. 2014
    ..Using claims data, the burden of SREs as a group has been reported among patients with cancer. We investigate the mortality impact of subcomponents of SREs, a topic that has received limited attention among older men...
  3. pmc Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    BMC Med Res Methodol 14:1. 2014
    ..The prevalence and consequences of bone metastases (BM) have been examined across tumor sites using healthcare claims data however the reliability of these claims-based BM measures has not been investigated...
  4. doi request reprint Readmissions after unauthorized discharges in the cardiovascular setting
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 49:215-24. 2011
    ....
  5. ncbi request reprint Racial differences in hospital discharge disposition among stroke patients in Maryland
    Ebere Onukwugha
    University of Maryland, School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, MD 21201, USA
    Med Decis Making 27:233-42. 2007
    ..The objective of this retrospective study was to assess the evidence for racial differences in discharge disposition among patients hospitalized for stroke...
  6. ncbi request reprint Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease
    Ebere Chukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Ethn Dis 19:172-8. 2009
    ..Disparities in discharges AMA have not been examined among patients with cardiovascular disease, nor has the moderating role of hospital quality been studied...
  7. ncbi request reprint The total economic burden of overactive bladder in the United States: a disease-specific approach
    Ebere Onukwugha
    Department of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA
    Am J Manag Care 15:S90-7. 2009
    ..To employ results from a recent US population-based survey to calculate disease-specific total costs of overactive bladder (OAB)...
  8. doi request reprint The dual impact of rehabilitation admission and race/ethnicity on discharges against medical advice
    E Onukwugha
    Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    NeuroRehabilitation 24:67-74. 2009
    ..However, the predictive effect of an admission for rehabilitative care has not been examined in an inpatient stroke population, nor has the impact of race/ethnicity on this relationship been reported...
  9. doi request reprint Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system
    Ebere Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
    Value Health 11:980-8. 2008
    ..To identify a cost-saving subset of criteria for the use of tiotropium at a Veterans Affairs Medical Center based on a cost-effectiveness analysis with ipratropium as the comparator...
  10. doi request reprint Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Urology 77:1088-95. 2011
    ..The role of specialists in the management of advanced PCa is evolving in response to positive chemotherapy trials of PCa...
  11. ncbi request reprint Hospital Center Effect for Laparoscopic Colectomy Among Elderly Stage I-III Colon Cancer Patients
    Zhiyuan Zheng
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy Department of Surgery, Division of General and Oncologic Surgery, University of Maryland School of Medicine, Baltimore, MD
    Ann Surg 259:924-9. 2014
    ..To investigate hospital-level variation in short-term laparoscopic colectomy outcomes among stage I-III elderly colon cancer patients...
  12. pmc Health disparities in staging of SEER-medicare prostate cancer patients in the United States
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Urology 76:566-72. 2010
    ..To examine whether race or age disparities affected the odds of being staged among prostate cancer (PC) patients. Accurate staging is critical for determining treatment for PC...
  13. pmc Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
    Zhiyuan Zheng
    University of Maryland School of Pharmacy, Baltimore, MD, USA
    Adv Ther 31:724-34. 2014
    ..This analysis investigated the survival benefit and incremental cost associated with Tx2 among elderly mCC patients...
  14. doi request reprint Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis
    Myra Schneider
    School of Pharmacy, University of Maryland Baltimore, Maryland, USA
    J Am Geriatr Soc 59:637-46. 2011
    ..To investigate the survival benefit associated with chemotherapy receipt in older women with estrogen receptor-negative (ER-) Stage IV breast cancer...
  15. ncbi request reprint The use of health services among elderly patients with stage IV prostate cancer in the initial period following diagnosis
    Candice Yong
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, United States Electronic address
    J Geriatr Oncol 5:290-8. 2014
    ..We evaluated health services utilization among elderly men with stage IV PCa with (M1) and without (M0) distant metastasis during the year following diagnosis...
  16. ncbi request reprint The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model
    Nirupama D Mitikiri
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA
    J Comp Eff Res 2:605-18. 2013
    ..This article reviews evidence regarding HTE in stage IV prostate cancer (S4PC)...
  17. pmc Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
    Zhiyuan Zheng
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD
    Cancer Med 3:124-33. 2014
    ..Elderly mCC patients, their health care providers, and policy makers will benefit from new evidence about the impact of sequencing of treatment lines...
  18. ncbi request reprint Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 47:1229-36. 2009
    ..Recent healthcare system and environmental changes may have reduced treatment gaps...
  19. doi request reprint Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer
    Ilene H Zuckerman
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Am Geriatr Soc 57:1403-10. 2009
    ..To estimate the modifying effect of age on the survival benefit associated with adjuvant chemotherapy receipt in elderly patients with a diagnosis of Stage III colon cancer...
  20. ncbi request reprint Engaging hard-to-reach patients in patient-centered outcomes research
    Karen S Kauffman
    University of Maryland School of Nursing, 655 West Lombard Street, Baltimore, MD 21201, USA
    J Comp Eff Res 2:313-24. 2013
    ..This study aimed to identify methods to engage hard-to-reach patients in the research process...
  21. pmc Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients
    Emily S Reese
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, Maryland
    Cancer Med 2:907-15. 2013
    ..Additional research is warranted to understand the role of physician versus patient preferences as well as geographic differences explaining why patients advance through lines of chemotherapy...
  22. pmc A sustainable strategy to prevent misuse of antibiotics for acute respiratory infections
    Gail B Rattinger
    Veterans Affairs Maryland Health Care System, Baltimore, MD, USA
    PLoS ONE 7:e51147. 2012
    ..Could a clinical decision support system (CDSS), interposed at the time of electronic prescription, adjust antibiotics utilization toward consensus treatment guidelines for ARI?..
  23. pmc Racial variation in the cost-effectiveness of chemotherapy for prostate cancer
    Michael Grabner
    University of Maryland School of Pharmacy, Baltimore, MD and University of Georgia College of Pharmacy, Athens, GA
    J Oncol Pract 7:e16s-24s. 2011
    ....
  24. ncbi request reprint Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer
    Candice Yong
    University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Curr Opin Oncol 26:274-83. 2014
    ....
  25. ncbi request reprint Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Cancer 118:3173-81. 2012
    ..Whether the benefits of these agents justify the additional costs for elderly Medicare recipients is particularly policy relevant after US health care reform...
  26. doi request reprint Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US
    John F P Bridges
    Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Pharmacoeconomics 28:175-84. 2010
    ..We conclude that while a threshold may be needed to interpret the results of a cost-effectiveness analysis, that threshold must vary across payers, populations and even procedures...
  27. doi request reprint The potential impact of comparative effectiveness research on the health of minority populations
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Health Aff (Millwood) 29:2098-104. 2010
    ..We also recommend the increased recruitment of minorities for clinical trials, and such measures as using community health workers to translate research results in ways that will increase their relevance to minority patients...
  28. ncbi request reprint Racial variation in the cost-effectiveness of chemotherapy for prostate cancer
    Michael Grabner
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Am J Manag Care 17:e151-9. 2011
    ....
  29. pmc Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel
    Emily S Reese
    School of Pharmacy, University of Maryland, Baltimore, Maryland, USA
    Pharmacotherapy 32:323-32. 2012
    ..To estimate the cost-effectiveness of genotype-guided selection of antiplatelet therapy compared with selecting clopidogrel or prasugrel irrespective of genotype...